Myocardial stunning and hibernation revisited

Gerd Heusch1

  • 1Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany. gerd.heusch@uk-essen.de.

Insights

Myocardial stunning and hibernation involve reversible heart muscle dysfunction after ischemia. Understanding their pathophysiology is key for guiding revascularization treatments and improving patient outcomes.

Area of Science:

  • Cardiology
  • Physiology
  • Pathophysiology

Background:

  • Myocardial stunning and hibernation are distinct forms of reversible myocardial ischemia-reperfusion injury.
  • Unlike acute myocardial infarction, these conditions feature contractile dysfunction as the primary endpoint.
  • They differ in duration, reversibility, and underlying mechanisms.

Purpose of the Study:

  • To review the current understanding of the pathophysiology of myocardial stunning and hibernation.
  • To highlight the clinical implications of these myocardial conditions.
  • To inform more precise indications for revascularization therapies.

Main Methods:

  • Review of existing literature on myocardial stunning and hibernation.
  • Analysis of the mechanisms of reactive oxygen species formation and excitation-contraction coupling alterations.
  • Examination of metabolic and morphological changes in hibernating myocardium.

Main Results:

  • Myocardial stunning involves prolonged, reversible contractile dysfunction post-ischemia due to reactive oxygen species and altered excitation-contraction coupling.
  • Hibernating myocardium exhibits reduced function and blood flow, with recovery post-revascularization.
  • Chronic hibernation involves significant morphological and molecular adaptations.

Conclusions:

  • A deeper understanding of stunning and hibernation pathophysiology is crucial for optimizing revascularization strategies.
  • These conditions necessitate careful clinical recognition and management.
  • Further research can refine treatment decisions in chronic coronary syndromes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
147
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
160
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
192